title: Effects of metronidazole on periodontal treatment needs.
abstract: Periodontitis, a common cause of tooth loss in adult populations, is an inflammatory response to the overgrowth of anaerobic organisms such as spirochetes and bacteroides and, in some cases, micro-aerophilic organisms in the subgingival plaque. In the present investigation, using a double-blind clinical design, we sought to determine whether 1 week of metronidazole treatment plus debridement of the tooth surfaces was superior to 1 week of placebo treatment plus debridement (positive control) in reducing the subsequent amount of periodontal surgery given to the patients. Thirty-nine patients were randomly assigned to either the metronidazole or placebo (positive control) groups. All patients were given the necessary scaling and root planing and were unsupervised in their usage of the medication. After the completion of this treatment, they were reexamined and it was found that the metronidazole regimen caused a significant reduction in surgical needs of about 5 teeth per patient compared to the positive control (difference before and after treatment 8.3 +/- 6.8 teeth metronidazole versus 2.9 +/- 4.8 positive control, P = 0.007). The difference between groups was maintained during the 2 to 3 years' recall period. Metronidazole had a significant effect on the site specific reduction of spirochetes: 90% of the sites in the metronidazole group versus 64% in the positive-control group had a decrease in the percentage of spirochetes (P less than 0.05). We conclude that systemic metronidazole given 250 mg tid for 7 days in conjunction with debridement of the tooth surfaces can significantly reduce the need for periodontal surgery compared to the standard regimen which included only debridement.
authors.affiliation: Department of Biologic and Materials Sciences, University of Michigan, School of Dentistry, Ann Arbor.
authors.forename: W J
authors.initials: WJ
authors.lastname: Loesche
authors.forename: E
authors.initials: E
authors.lastname: Schmidt
authors.forename: B A
authors.initials: BA
authors.lastname: Smith
authors.forename: E C
authors.initials: EC
authors.lastname: Morrison
authors.forename: R
authors.initials: R
authors.lastname: Caffesse
authors.forename: P P
authors.initials: PP
authors.lastname: Hujoel
mesh_terms: D016301:Alveolar Bone Loss / Q000473:pathology / Q000503:physiopathology; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification; D003773:Dental Plaque / Q000382:microbiology; D012534:Dental Scaling; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use*; D008875:Middle Aged; D010347:Patient Care Planning; D010518:Periodontitis / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D010919:Placebos; D013144:Spirochaetales / Q000187:drug effects / Q000302:isolation & purification; D013997:Time Factors; D014081:Tooth Extraction; D014092:Tooth Root / Q000601:surgery
chemical_list: D010919:Placebos; D008795:Metronidazole